FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Nomax Rose Bengal GloStrips Recall

Rose Bengal GloStrips (rose bengal) Ophthalmic Strips USP, 1

Nomax Inc · Saint Louis, MO

Risk level
Class III
Reported by FDA
Apr 29, 2015
Recall ID
D-0962-2015
Check your lot numberHow we source this data

Summary

Nomax recalled Rose Bengal GloStrips starting Mar 24, 2015. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0962-2015 on Apr 29, 2015. Reason: Failed Content Uniformity Specifications: The product may not meet finished product release specifications, including the uniformity of dosage due to a packaging degradation related to the adhesive component of the paper pouch that can impact the level of rose bengal present in the strips. Status: Terminated.

Why it was recalled

Failed Content Uniformity Specifications: The product may not meet finished product release specifications, including the uniformity of dosage due to a packaging degradation related to the adhesive component of the paper pouch that can impact the level of rose bengal present in the strips.

Product description

Rose Bengal GloStrips (rose bengal) Ophthalmic Strips USP, 1.3 mg per strip, individually wrapped strip (NDC 51801-004-01), barcode (01)00351801004019, packaged in 100-count strips per carton (NDC 51801-004-40, UPC 3 51801 00440 8), Nomax, Inc., St. Louis, MO 63123 USA.

Lot numbers, UPCs & expiration codes

Lot #: 8925, Exp 07/17; 8972, Exp 10/17; and 9195, Exp 04/18

Where it was sold

Nationwide and Puerto Rico, Australia, Brazil, Canada, Chile, Colombia, Dominican Republic, Honduras, Iceland, Israel, Jamaica, Trinidad and Tobago, and St. Lucia

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0962-2015
Classification
Class III
Status
Terminated
Recall initiated
Mar 24, 2015
FDA report date
Apr 29, 2015
Quantity
5,514 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Nomax Inc

Original FDA data

Every field from FDA enforcement report D-0962-2015, exactly as published.

Show all FDA fields
City
Saint Louis
State
MO
Status
Terminated
Country
United States
Event ID
70552
Address
9735 Green Park Industrial Dr
Code information
Lot #: 8925, Exp 07/17; 8972, Exp 10/17; and 9195, Exp 04/18
Postal code
63123-7241
Report date
Apr 29, 2015
Product type
Drugs
Recall number
D-0962-2015
Classification
Class III
Recalling firm
Nomax Inc
Product quantity
5,514 cartons
Termination date
Feb 21, 2017
Reason for recall
Failed Content Uniformity Specifications: The product may not meet finished product release specifications, including the uniformity of dosage due to a packaging degradation related to the adhesive component of the paper pouch that can impact the level of rose bengal present in the strips.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Rose Bengal GloStrips (rose bengal) Ophthalmic Strips USP, 1.3 mg per strip, individually wrapped strip (NDC 51801-004-01), barcode (01)00351801004019, packaged in 100-count strips per carton (NDC 51801-004-40, UPC 3 51801 00440 8), Nomax, Inc., St. Louis, MO 63123 USA.
Distribution pattern
Nationwide and Puerto Rico, Australia, Brazil, Canada, Chile, Colombia, Dominican Republic, Honduras, Iceland, Israel, Jamaica, Trinidad and Tobago, and St. Lucia
Recall initiation date
Mar 24, 2015
Initial firm notification
Letter
Center classification date
Apr 21, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0962-2015, published Apr 29, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls